Company / Current Assets per Share
Janux Therapeutics, Inc. Current Assets per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$15.75
FY2025
5-year range
$7.93 / $19.23
FY2021-FY2025
Trend
-18.1%
vs FY2024
Sector context
#42 of 212
Health Care
What the data says
Janux Therapeutics, Inc.'s current assets per share of $15.75 is higher than 80% of companies in the Health Care sector (FY2025). Improved from $7.93 to $15.75 over the past 2 years.
Based on SEC 10-K filings.
15.75 in FY2025 with a 5-year CAGR of -2.1%. Top quartile in the Health Care sector.
Improved from $7.93 to $15.75 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- +25.2%
- 5-Year CAGR
- -2.1%
- 10-Year CAGR
- -
Sector benchmark
Top 20% in Health CareTop 20% of 212This company $15.75 Sector average $133.20
▼
-88.2% below sector average
Key checks
Key Insights
- In FY2025, current assets per share decreased 18.1% year-over-year.
- Ranks #42 out of 212 companies in the Health Care sector.
- Peak current assets per share was recorded in FY2024.
- Lowest current assets per share in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 9.17 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $15.75 | -18.1% |
| FY2024 | $19.23 | +142.4% |
| FY2023 | $7.93 | -1.0% |
| FY2022 | $8.02 | -50.0% |
| FY2021 | $16.02 | -8.7% |
| FY2020 | $17.55 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026